Intellectual Property



Mueller J.M., Facilitating Patient Access to Patent-Protected Genetic Testing, Journal of Business & Technology Law, Vol. 6, No. 1, 2010





SIMON B.M., How To Get a Fair Share: IP Policies For Publicly Supported Biobanks, Stanford Journalof Law, Science and Policy, 2009 


VAN OVERWALLE G. (ed.), Gene Patents and Collaborative Licensing Models. Patent Pools, Clearinghouses, Open Source Models and Liability Regimes, Cambridge, Cambridge University Press, 2009




GOLD R., CARBONE J., Myriad Genetics: In the Eye of the Policy Storm, 2008, in rete,




HOLMAN C.M, The Impact of Human Gene Patents on Innovation and Access: A Survey of Human Gene Patent Litigation, 76 UMKC L. Rev. 295 (2007)

HOPKINS M.M., MAHDI S., PATEL P., THOMAS S.M., DNA Patenting: The End o fan Era?, 25 Nat. Biotech, 185 (2007)


CAFORIO G., I trovati biotecnologici tra i principi etico-giuridici e il codice di proprietà industriale, Torino, 2006


CAULFIELD T., COOK-DEEGAN R.M., KIEFF F.S.,WALSH J.P., Evidence and Anectodes: an Analysis of Human Gene Patenting Controversies, 24 Nature Biotech, 1091 (2006)

GREENFIELD D.L., Greenberg v. Miami Children’s Hospital: Unjust Enrichment and the Patenting of Human Genetic Material, 15 Annals of Health Law, 213 (2006)


EBERSOLE T.J., GUTHRIE M.C., GOLDSTEIN J.A., Patent Pool as a Solution to The Licensing Problems of Diagnostics Genetics, 17 Intellect. Prop. Technol. Law J., 6 (2005)

GOLD R., CAULFIELD T., JOLY J., Genetic Research Tool, The Research Exception and Open Science, 3 GenEdit, 1 (2005)

JENSEN K., MURRAY F., Intellectual Property. Enhanced: Intellectual Property Landscape of Human Genome, 310 Science, 239 (2005)

LIIVAK O., The Forgotten Originality Requirement: A Constitutional Hurdle for Gene Patents, 87 J. Pat. & Trademark Off. Soc’y, 261 (2005)


MATTHIJS G., Patenting Genes May Slow Down Innovation, and Delay Availability of Cheaper Genetic Tests, 329 British Medical Journal, 1359 (2004)


CHO M.K., Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Service, 5 J. Molecular Diagnostics, 3 (2003)

CHO M., ILLANGASEKARE S., WEAVER M., LEONARD D., MERZ J., Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Service, 5 J. Mol. Diagn., 3 (2003)


ANDREWS L.B, Genes and Patent Policy: Rethinking Intellectual Property Rights, 3 Nat. Rev., 803 (2002)

ANDREWS L.B., The Gene Patent Dilemma: Balancing Commercial Incentives With Health Needs, 2 Houston Journal of Health Law & Policy, 65 (2002)

BARTON J.H., United States Law of Genomic and Post Genomic Patents, in 33 Intenational Review of Industrial Property and Copyright Law, 779 (2002)

GOLD R., CAULFIELD T., The Moral Toolboth: a Method that Makes Use of the Patent System to Address Ethical Concern in Biotechnology, 359 Lancet, 2268 (2002)


BOBROW M., THOMAS S., Patents in a Genetic Age, 409 Nature, 763 (2001)

FAELLI T., La tutela delle invenzioni biotecnologiche in Europa: prime valutazioni di insieme, in Dir. ind., 2001, I, 129


CAULFIELD T., GOLD R., CHO M.K., Patenting Human Genetic Material: Refocusing the Debate, 1 Nat. Rev., 227 (2000)


CAMPIGLIO C., I brevetti biotecnologici nel diritto comunitario, in Dir. comm. internaz., 1999, IV, 849

DI CATALDO V., La brevettabilità delle biotecnologie. Novità, attività inventiva, industrialità, in Dir. ind., I, 1999, 177

GUIDETTI B., La Direttiva 98/44/CE sulle invenzioni biotecnologiche, in Contratto e Impresa, 1999, I, 482


BAGGOT B., Patenting Transgenic in the European Union, 16(3) Nat. Biotechnol., 299 (1998)

BEGHÈ LORETI A., MARINI L., La protezione giuridica delle invenzioni biotecnologiche, in Diritto dell’Unione Europea, 4-1998, 793

HELLER M., EISENBERG R., Can Patents Deter Innovation? The Anticommons in Biomedical Research, 280 Science, 698 (1998)


CAPLAN A.L., MERZ J.F., Patenting Gene Sequences, 312 British Med. J., 926 (1996)


BEIER F.K. , MOUFANG R., Patentability of human genes and living organism, in Dir. ind., 1994, I, 340

GRUNWALD R., VOGEL F., Patenting of Human Genes and Living Organism, New York, 1994


CASUCCI G.F., Onco-mouse Harvard: 3° atto. Il problema della liceità, in Dir. ind., 1992, II, 158

EISENBERG R.S., Genes, Patents, and Product Development, 257 Science, 903 (1992)

KILEY T.D., Patents on Random Complementary DNA Fragments?, 257 Science, 915 (1992)

KO Y., An Economic Analysis of Biotechnology Patent, 102 Yale L. Rev., 1992, 777


DI CERBO V., “Il topo di Harvard” ovvero la manipolazione genetica di animali all’esame dell’Ufficio europeo dei brevetti, in Foro It., 1991, IV, 178

GREENFIELD M.S., Recombinant DNA Technology: A Science Struggling with the Patent Law, 44 Stanf. f. L. Rev., 1991, 1051


BEIER F.K., CRESPI R.S., STRAUSS J., Biotechnology and Patent Protection: an International Review, OCSE, 1985